Investigating the Role of LRG1 in Hepatosteatosis and Insulin Resistance in Obese Children
Journal of clinical research in pediatric endocrinology, cilt.18, sa.3, ss.431-439, 2026 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 18 Sayı: 3
- Basım Tarihi: 2026
- Doi Numarası: 10.4274/jcrpe.galenos.2026.2025-11-5
- Dergi Adı: Journal of clinical research in pediatric endocrinology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM), Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
- Sayfa Sayıları: ss.431-439
- Anahtar Kelimeler: adipokines, children, hepatosteatosis, insulin resistance, LRG1, obesity
- Akdeniz Üniversitesi Adresli: Evet
Özet
Objective: This study aimed to investigate the relationship between leucine-rich alpha-2-glycoprotein 1 (LRG1), hepatosteatosis, and insulin resistance (IR) in obese children, and to evaluate the potential role of LRG1 as a biomarker in these metabolic conditions. Methods: A cohort of obese and non-obese children were enrolled. Obese subjects were further grouped by hepatosteatosis and IR status. Anthropometric measurements, biochemical parameters, and inflammatory markers including LRG1, adiponectin, and tumor necrosis factor-α (TNF-α) were evaluated. Associations between these markers and metabolic parameters were analyzed. Results: The cohort consisted of 172 children, of whom 100 (58.1%) were obese and 72 were non-obese. Obese children had significantly higher body mass index (BMI), BMI standard deviation scores, waist and upper arm circumferences, triceps skinfold thickness, total and percentage body of fat (PBF), and elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP) (p<0.001). Laboratory findings revealed elevated glucose, insulin, homeostatic model assessment of IR (HOMA-IR), alanine aminotransferase, triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and lower high-density lipoprotein cholesterol (HDL-C) in the obese group (p<0.05). LRG1 levels did not differ by obesity or hepatosteatosis status but were significantly lower in those with IR (p=0.03). LRG1 was negatively correlated with waist circumference, DBP, insulin, HOMA-IR, TG, TC, and LDL-C, and positively with HDL-C (p<0.05). Adiponectin showed inverse correlations with waist circumference, SBP, insulin, HOMA-IR, TC, LDL-C, TG, and a positive correlation with HDL-C (p<0.05). Conclusion: Findings suggest LRG1 may not serve as a direct biomarker for hepatosteatosis in obese children but was negatively associated with IR and dyslipidemia. These results highlight a complex role for LRG1 in obesity-related metabolic dysfunction and support further longitudinal and pathophysiological studies.